Startups
At Augmedit, we're at the forefront of medical technology, where the power of augmented reality (AR) and extended Reality (XR) converge to transform the way surgeons and healthcare professionals operate and educate. Picture a world where surgeons effortlessly craft patient holograms with a few clicks, opening new avenues of patient engagement and communication. Our groundbreaking XR solutions bridge the gap between medical professionals and patients, offering a new dimension in healthcare communication. Envision patients and surgeons exploring and discussing their medical conditions and treatment options in an entirely immersive way. Or imagine pre-surgical planning collaborations between peers and colleagues... But that is just the beginning. At Augmedit, we believe in pushing the boundaries of what's possible by redefining neurosurgery with XR solutions designed to conquer neuro-navigation challenges within the operating room. Our commitment to medical innovation knows no bounds. Join us as we embark on a journey to revolutionize surgery, one hologram at a time. Together, we will forge a brighter, more efficient future for healthcare professionals and patients.
Overview
Employees
1-10
Total raised
$993.46K
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| AugmedIT B.V. | “Augmedit offers medical software that guides doctors through complicated surgeries with the help of augmented reality” |
Reviews 0
FAQ about Augmedit
How much funding has Augmedit raised?
Augmedit has raised $993.46K in total across 1 funding round.
What has the press written about Augmedit?
Parsers VC has collected 2 articles mentioning Augmedit, among them “AugmedIT B.V.”.
Is Augmedit still active?
Yes, Augmedit is active; its latest activity on Parsers VC dates from Dec 9, 2022.